Clinical Study Results
Where can I learn more about the study?
You can find more information about this study on the websites listed below. If a
full report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03358147”
into the search box and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“PT001102-04” into the search box and click “Find a Study”.
Full study title: A Randomized, Double-Blind, Parallel Group, Multi-Center
24-Week Study Comparing the Efficacy and Safety of Three Doses of PT001 to
Placebo and Open-label Spiriva® Respimat® in Subjects With Persistent Asthma
National Clinical Trial number: NCT03358147
Pearl Therapeutics, Inc Protocol Number: PT001102-04
Pearl Therapeutics, Inc., sponsored this study and has its headquarters in
Redwood City, CA, USA
The phone number for the AstraZeneca Information Center is
+1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part
in clinical research around the world. They help researchers answer important
health questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP)
is a non-profit organization focused on educating and informing the public about
clinical research participation. CISCRP is not involved in recruiting participants
for clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
12
Version 1.0 2020_06_11